This inventor holds 1 USPTO granted patent. Top assignee: University of Ulster. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Innovations of Yingjie Sheng in Cancer Therapy
Introduction
Yingjie Sheng is an accomplished inventor based in Coleraine, Londonderry, GB. He has made significant contributions to the field of cancer therapy through his innovative research and development of advanced therapeutic methods.
Latest Patents
Yingjie Sheng holds a patent for "Calcium peroxides nanoparticles as adjuvant therapy." This invention provides calcium oxide nanoparticles with a pH-responsive coating, designed for use in adjuvant therapy targeting hypoxic tumor cells or tissues. The nanoparticles are particularly effective in enhancing cancer therapies that rely on oxygen, such as photodynamic therapy (PDT), sonodynamic therapy (SDT), and radiotherapy. Additionally, the invention includes pharmaceutical compositions that contain the coated calcium oxide nanoparticles, along with at least one photosensitizer, sonosensitizer, or radiosensitizer, and optionally, at least one pharmaceutical carrier or excipient. Yingjie Sheng has 1 patent to his name.
Career Highlights
Yingjie Sheng is affiliated with the University of Ulster, where he continues to advance his research in cancer therapies. His work focuses on developing innovative solutions that can significantly improve treatment outcomes for patients suffering from cancer.
Collaborations
Yingjie Sheng has collaborated with notable colleagues, including Anthony Mchale and John Francis Callan, to further enhance the impact of his research and inventions.
Conclusion
Yingjie Sheng's innovative work in the field of cancer therapy exemplifies the potential of advanced therapeutic methods to improve patient outcomes. His contributions through patented inventions are paving the way for more effective cancer treatments.